Stada hires Weleda’s Marc van Boven
Premium
21 September 2021
Germany’s Stada has hired Weleda’s Marc van Boven as head of Consumer Health Germany.
Industry News - Tag: Stada
You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
Stada hires Weleda’s Marc van Boven
Stada and NTC strike ophthalmic deal in MENA
Premium
9 September 2021
Germany’s Stada and Italy’s NTC have announced a commercial ophthalmic partnership in the Middle East and North Africa (MENA) region.
Stada strikes Nordic agreement with Medis
Premium
27 August 2021
Stada Nordic is boosting its consumer healthcare portfolio through a commercial partnership with Slovenia’s Medis Consumer Health covering its topical analgesic Rowiren.
Stada steps up US presence with Friska acquisition
Premium
26 August 2021
Stada has boosted its consumer healthcare presence in the US by acquiring vitamins, minerals and supplements (VMS) specialist Friska.
Acquisitions help lift Stada up OTC rankings
Premium
26 August 2021
Acquisitions helped lift sales at Stada’s Branded Products division by 13% in the first half of 2021. Chief executive officer Peter Goldschmidt said Stada was now the fourth-largest OTC player in Europe.
Sanofi and Stada strike major distribution deal
Premium
28 July 2021
Sanofi is handing over distribution and marketing of around 50 consumer healthcare brands in 20 European countries to Germany’s Stada.
Stada launches Austria’s first OTC triptan
15 July 2021
Stada has launched Austria’s first non-prescription migraine treatment containing a triptan. The Austrian initiative was “tailored to the local market conditions and opportunities”, Stada told OTCToolbox, adding that the company “continues to explore opportunities for prescription-to-OTC switches wh...
Stada and Enzymatica add Vietnam to partnership
Premium
13 July 2021
Stada has inlicensed exclusive rights to Enzymatica’s ViruProtect in Vietnam and plans to launch the common cold spray in the country in 2022.
Stada snaps up portfolio of brands from Sanofi
Premium
29 June 2021
Stada is strengthening its European consumer healthcare presence by acquiring 16 local and regional brands – including Silomat, Mitosyl and Frubiase – from Sanofi Consumer Healthcare for an undisclosed sum.
One in four Europeans trust pharma firms on health
Premium
21 June 2021
Nearly one in four Europeans, 24%, trust pharmaceutical companies on health issues, according to the Stada Health Report 2021.